EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer

Rocio Seniuk, Pablo Sanchis iD, Agustina Sabater iD, Gaston Pascual iD, Juan Bizzotto iD, Julia Lechuga, Magdalena Delfino, Peter D A Shepherd iD, Jiabin Dong, María Pia Valacco iD, Javier Cotignola iD, Elba Vazquez iD und 3 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Rocio Seniuk und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Heme Oxygenase-1, Cell Transdifferentiation, Cell Nucleus. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Center Prostate Cancer SPORE, NCI NIH HHS, David H. Koch Center for Applied Research in Genitourinary Cancers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine prostate cancer (NEPC) is characterized by androgen receptor (AR) independence and poor response to conventional therapies, highlighting the need to unveil the molecular mechanisms behind NEPC. We previously showed that heme oxygenase 1 (HO-1, encoded by HMOX1) translocates to the nucleus exerting unexplored non-canonical functions. The present study delineates the nuclear interactome of HO-1, revealing a potential mechanism that impairs NEPC establishment. Through a proteomics approach integrated with bioinformatics analyses, we identified eleven novel nuclear interactors of HO-1. Unsupervised clustering analyses of RNA-seq data from prostate cancer (PCa) patient-derived xenografts (MDA PCa PDXs) and clinical cohorts demonstrated high expression of three HO-1 interactors (ILF3, SAFB, BCLAF1, and DDX17) in NEPC samples, with concomitant HMOX1 under-expression. Spatial transcriptomics in a mixed-histology tumor confirmed enrichment of the interactors in the NEPC foci. To better understand the link between HO-1 and NEPC, we established and characterized an in vitro model of NE transdifferentiation in PCa cell lines using forskolin to induce phenotypic reprogramming. HO-1 upregulation in transdifferentiated cells significantly attenuated the expression of NE markers and triggered a morphological shift, restoring epithelial phenotypes. This work identifies for the first time HO-1 nuclear interactome association with NEPC, where the HMOX1-ILF3-SAFB-BCLAF1-DDX17 print emerges as a useful marker for disease stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsHeme Oxygenase-1Cell TransdifferentiationCell NucleusNeuroendocrine CellsHumansMaleCell Line, TumorGene Expression Regulation, NeoplasticAnimalsRepressor ProteinsTumor Suppressor Proteins

Stichwörter der Autor:innen

heme-oxygenase 1neuroendocrine transdifferentiationnuclear interactomeprostate cancer

Substanzen

Heme Oxygenase-1HMOX1 protein, humanRepressor ProteinsBCLAF1 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.
  • Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), CONICET-Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.
  • Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Instituto de Tecnología (INTEC), Universidad Argentina de la Empresa (UADE), Buenos Aires C1073AAO, Argentina.

ORCID-Profile: Pablo Sanchis, Agustina Sabater, Gaston Pascual, Juan Bizzotto, Peter D A Shepherd, María Pia Valacco, Javier Cotignola, Elba Vazquez, Ayelen Toro, Geraldine Gueron, Estefania Labanca

Förderung

  • Cancer Center Prostate Cancer SPORE
  • NCI NIH HHS
  • David H. Koch Center for Applied Research in Genitourinary Cancers
  • Prostate Cancer Foundation

Zitieren

APA

Seniuk, R., Sanchis, P., Sabater, A., Pascual, G., Bizzotto, J., Lechuga, J., Delfino, M., Shepherd, P. D. A., Dong, J., Valacco, M. P., Cotignola, J., Vazquez, E., Toro, A., Gueron, G., & Labanca, E. (2026). HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177635

Vancouver

Seniuk R, Sanchis P, Sabater A, Pascual G, Bizzotto J, Lechuga J, et al. HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177635

BibTeX
@article{Seniuk2026,
  author = {Seniuk, Rocio and Sanchis, Pablo and Sabater, Agustina and Pascual, Gaston and Bizzotto, Juan and Lechuga, Julia and Delfino, Magdalena and Shepherd, Peter D A and Dong, Jiabin and Valacco, María Pia and Cotignola, Javier and Vazquez, Elba and Toro, Ayelen and Gueron, Geraldine and Labanca, Estefania},
  title = {HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177635}
}
Kostenlos starten →